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The search among plant and animal tissues for an- 
ticancer agents has provided us with some of the 
drugs most widely used today for cancer treat- 
ment. Indeed, about one quarter of all drugs used 
in Western medicine are said to be derived from 
plants. Programmes of search and discovery at the 
National Cancer Institute have demonstrated, over 
the years, that some 3-4070 of plants studied pro- 
duce a variety of structurally unrelated anticancer 
agents. Extending these examinations to marine in- 
vertebrates and vertebrates, about 9-10% of 
marine animals furnish active neoplastic agents. 
The sea hare and sea mat have, apparently, yielded 
the most active anticancer agents (dolastatins and 
bryostatins) yet demonstrated. 
The discovery, isolation and synthesis of new 
anticancer agents has greatly accelerated over the 
years, but the lag between discovery and eventual 
clinical application appears to grow ever longer 
and in some cases can take up to 20 years. These 
and many other interesting facts about new 
biologically derived antitumour compounds are 
contained in the short introduction to this topic. 
The book consists almost entirely of chemical 
formulae and contains 21 chapters divided into 4 
sections, dealing with total synthetic approaches to 
naturally occurring anticancer agents, new biosyn- 
thetic agents, marine animal and marine plant 
products. The format is a ‘camera-ready’ presenta- 
tion with most of the structural formulae hand- 
drawn. This style was adopted, apparently, to 
speed up the publication process and substantially 
reduce production costs. However, the price at 
$159.25 is very high. Nevertheless, the book will be 
of great value to chemists specialising in the 
development of new anticancer agents. 
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This publication comprises 12 chapters, each writ- 
ten by an expert or experts, each separately bound, 
and all contained in a serviceable plastic-covered 
box. The intention of the Editors of the series is to 
review periodically the basic material and when 
necessary to produce supplements to keep the 
subscriber up-to-date with recent developments. 
The individual chapters cover cloning in 
bacteriophage, cosmid libraries, gene cloning in 
yeast, use of cloning vectors to obtain expression 
of eukaryotic gene products in bacteria, transcrip- 
tion mapping and gene identification using hybrid 
selection and hybrid arrest of translation, DNA 
mediated gene transfer by the calcium technique, 
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